Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis

Clinical and Experimental Medicine

Volumn 14, Issue 3, 2014, Pages 275-283

  Neve, Anna ^a   Corrado, Addolorata ^a   Cantatore, Francesco Paolo ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Monocytes macrophages; Rheumatoid arthritis; TNF ; Vitamin D

Indexed keywords

CYTOKINE; IMMUNOLOGIC FACTOR; NITRIC OXIDE; VITAMIN D;

ADULT; AGED; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MACROPHAGE; MALE; METABOLISM; MIDDLE AGED; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC FACTORS; MACROPHAGES; MALE; MIDDLE AGED; NITRIC OXIDE; VITAMIN D;

EID: 84905122135     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-013-0249-2     Document Type: Article

References (44)

1. Maruotti N, Cantatore FP. (2010) Vitamin D and the immune system. J Rheumatol 37(3):491-495 [Epub 2010 Jan 15]
2. Choy EH (2006) Joint inflammation and cytokine inhibition in rheumatoid arthritis. Clin Exp Med 6:13-19
3. Maruotti N, Cantatore FP, Crivellato E et al (2007) Macrophages in rheumatoid arthritis. Histol Histopathol 22:581-586 (Pubitemid 46647270)
4. Mulherin D, Fitzgerald O, Bresnihan B (1996) Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 39:115-124 (Pubitemid 26036386)
5. Hummel KM, Petrow PK, Franz JK et al (1998) Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol 25:1887-1894 (Pubitemid 28459300)
6. Hou WS, Li W, Keyszer G et al (2002) Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. Arthritis Rheum 46:663-674 (Pubitemid 34214249)
7. Schulze-Koops H, Davis LS, Kavanaugh AF et al (1997) Elevated cytokine messenger RNA levels in the peripheral blood of patients with rheumatoid arthritis suggest different degrees of myeloid cell activation. Arthritis Rheum 40:639-647 (Pubitemid 27157568)
8. Lioté F, Boval-Boizard B, Weill D et al (1996) Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release. Clin Exp Immunol 106:13-19 (Pubitemid 26329373)
9. Lavagno L, Gunella G, Bardelli C et al (2004) Anti-inflammatory drugs and tumor necrosis factor-alpha production from monocytes: role of transcription factor NF-kappa B and implication for rheumatoid arthritis therapy. Eur J Pharmacol 501:199-208 (Pubitemid 39298953)
10. Aletaha D, Neogi T, Silman AJ et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569-2581
11. Rausch-Fan X, Leutmezer F, Willheim M et al (2002) Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3. Int Arch Allergy Immunol 128:33-41 (Pubitemid 34621664)
12. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101-1108 (Pubitemid 351818697)
13. Cantorna MT, Hayes CE, DeLuca HF (1996) 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 93:7861-7864 (Pubitemid 26277129)
14. Cutolo M, Otsa K, Laas K et al (2006) Circannual Vitamin D serum levels and disease activity in rheumatoid arthritis: northern versus Southern Europe. Clin Exp Rheumatol 24:702-704 (Pubitemid 46138805)
15. Andjelkovic Z, Vojinovic J, Pejnovic N et al (1999) Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 17:453-456 (Pubitemid 29343630)
16. Cantorna MT, Hayes CE, DeLuca HF (1998) 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 128:68-72 (Pubitemid 28087178)
17. Caporali R, Sarzi-Puttini P, Atzeni F et al (2010) Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry. Autoimmun Rev 9:465-469
18. Atzeni F, Sarzi-Puttini P, Gorla R, Marchesoni A, Caporali R (2011) Switching rheumatoid arthritis treatments: an update. Autoimmun Rev 10:397-403
19. Alsalameh S, Winter K, Al-Ward R, Wendler J, Kalden JR, Kinne RW (1999) Distribution of TNF-alpha, TNF-R55 and TNF-R75 in the rheumatoid synovial membrane: TNF receptors are localized preferentially in the lining layer; TNF-alpha is distributed mainly in the vicinity of TNF receptors in the deeper layers. Scand J Immunol 49:278-285 (Pubitemid 29119438)
20. Georgopoulos S, Plows D, Kollias G (1996) Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J Inflamm 46:86-97 (Pubitemid 26180840)
21. Alexopoulou L, Pasparakis M, Kollias G (1997) A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur J Immunol 27:2588-2592 (Pubitemid 27453848)
22. Kinne RW, Bräuer R, Stuhlmüller B et al (2000) Macrophages in rheumatoid arthritis. Arthritis Res 2:189-202 (Pubitemid 32223726)
23. McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7:429-442 (Pubitemid 46834849)
24. Obermeier F, Gross V, Schölmerich J (1999) Interleukin-1 production by mouse macrophages is regulated in a feedback fashion by nitric oxide. J Leukoc Biol 66:829-836 (Pubitemid 29532046)
25. Baugh JA, Donnelly SC (2003) Macrophage migration inhibitory factor: a neuroendocrine modulator of chronic inflammation. J Endocrinol 179:15-23 (Pubitemid 37321563)
26. Zhang Y, Leung DY, Richers BN et al (2012) Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 188:2127-2135
27. Rego D, Kumar A, Nilchi L, Wright K, Huang S, Kozlowski M (2011) IL-6 production is positively regulated by two distinct Src homology domain 2-containing tyrosine phosphatase-1 (SHP-1)-dependent CCAAT/enhancer-binding protein β and NF-κB pathways and an SHP-1-independent NF-κB pathway in lipopolysaccharide-stimulated bone marrow-derived macrophages. J Immunol 186:5443-5456
28. Geng Y, Zhang B, Lotz M (1993) Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol 151:6692-6700 (Pubitemid 24001043)
29. Nagy G, Koncz A, Fernandez D et al (2007) Nitric oxide, mitochondrial hyperpolarization, and T cell activation. Free Radic Biol Med 42:1625-1631 (Pubitemid 46629013)
30. Chae HJ, Park RK, Chung HT et al (1997) Nitric oxide is a regulator of bone remodelling. J Pharm Pharmacol 49:897-902
31. Miesel R, Murphy MP, Kröger H (1996) Enhanced mitochondrial radical production in patients with rheumatoid arthritis correlates with elevated levels of tumor necrosis factor alpha in plasma. Free Radic Res 25:161-169 (Pubitemid 26345346)
32. Neve A, Corrado A, Cantatore FP (2011) Osteoblast physiology in normal and pathological conditions. Cell Tissue Res 343:289-302
33. Pettit AR, Walsh NC, Manning C et al (2006) RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis. Rheumatology (Oxford) 45:1068-1076 (Pubitemid 44542091)
34. Gravallese EM, Harada Y, Wang JT et al (1998) Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152:943-951 (Pubitemid 28173356)
35. Pettit AR, Ji H, von Stechow D et al (2001) TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 159:1689-1699 (Pubitemid 33062512)
36. Kong YY, Feige U, Sarosi I et al (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304-309
37. Redlich K, Hayer S, Maier A et al (2002) Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum 46:785-792 (Pubitemid 34214261)
38. Lubberts E, van den Bersselaar L, Oppers-Walgreen B et al (2003) IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol 170:2655-2662 (Pubitemid 36245658)
39. Corrado A, Neve A, Macchiarola A, Gaudio A, Marucci A, Cantatore FP (2013) RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects. J Rheumatol 40:684-694
40. Thomas GP, Baker SU, Eisman JA, Gardiner EM (2001) Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J Endocrinol 170:451-460 (Pubitemid 32771446)
41. Takasu H (2008) Anti-osteoclastogenic action of active vitamin D. Nutr Rev 66(10 Suppl 2):S113-S115
42. Maruotti N, Grano M, Colucci S et al (2011) Osteoclastogenesis and arthritis. Clin Exp Med 11:137-145
43. Fuller K, Murphy C, Firstein B, Fox SW, Chambers TJ (2002) TNFalpha potently activates osteoclasts, though a direct action independent and strongly synergistic with RANKL. Endocrinology 143:1108-1118 (Pubitemid 34164059)
44. Luo J, Wen H, Guo H, Cai Q, Li S, Li X (2013) 1,25-Dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis. Biomed Res Int 2013:101805. doi:10.1155/2013/101805 [Epub 2013 Apr 22]